MRLB-11055 demonstrated a dose-dependent trend towards WBC reduction, that did not reach statistical significance.
← all excerpts
Efficacious intermittent dosing of a novel JAK2 inhibitor in mouse models of polycythemia vera.
1
—
—
MRLB-11055 demonstrated a dose-dependent trend towards WBC reduction, that did not reach statistical significance.